• Long-term complications after transplant: diabetes and cancer

  • Long-term complications after transplant: diabetes and cancer

  • Long-term complications after transplant: diabetes and cancer

#Immunosuppression #Oceania

Live Session:

Friday, July 9, 2021 - 9:00 AM (Local time in Sydney)
Local time (Corresponding local time at your current location)

Join us:


Register

Description:


This masterclass will discuss the epidemiology, complications, and treatment strategies for the two major adverse outcomes after transplantation: cancer and diabetes.

Learning Objectives:


  • Understand the current epidemiology, screening, early detection, and treatment strategies for cancer after transplantation

  • Understand the current epidemiology, the burden of disease, screening and preventive and treatment strategies for diabetes after transplantation

Faculty:


Cancer after transplantation: epidemiology and novel therapies


Chris Blosser 

Clinical Associate Professor of Medicine
University of Washington 
Seattle, USA

Chris Blosser, MD, is a Clinical Associate Professor of Medicine at the University of Washington where he cares for adults with kidney disease, and is Director of the upcoming multidisciplinary Comprehensive Cancer & Organ Transplant Consult Clinic (CCOTCC), a partnership with SCCA and UW Transplant, to provide expert consultation for pre-and post-organ transplant patients with challenging cancer and organ transplant conditions. He also directs the Kidney Transplant Transition of Care Program from Seattle Children’s Hospital to UW Medical Center. He is focused on translational and clinical research regarding immunologic mechanisms and patient experience with cancer in pre-and post-organ transplant patients along with therapeutic interventions for various forms of allograft rejection, recurrent disease, and cancer in ESKD and organ transplant recipients. 

New onset diabetes after transplantation: epidemiology and management


Wai Lim

Medical Director of Kidney Transplantation
Sir Charles Gairdner Hospital
Clinical Professor of Medicine
University of Western Australia
Perth, Australia

Wai Lim is the Medical Director of Kidney Transplantation at Sir Charles Gairdner Hospital and a Clinical Professor of Medicine at the University of Western Australia. He is the iCo-Chair of the Transplantation Society of Australia and New Zealand Scientific Program Education Committee and Chair of the Australian Kidney Trials Network Transplant working group. He holds a Ph.D. in transplant immunology focussing on dendritic cells and chronic kidney disease and his current research interests focus on the role of HLA and epitope matching in kidney allocation for transplantation, novel immunological risk profile and identifying novel risk factors and intervention to reduce the risk of cardiovascular complications in kidney transplant patients. He is the Associate Editor for Transplant International, Nephrology and Frontiers Immunology, and Alloimmunity journals and is on the editorial board for Kidney International journal. 

Schedule (90 min):


  • 05 min

    Welcome and introduction by the Chair
  • 25 min

    Presentation: Cancer after transplantation: epidemiology and novel therapies, Chris Blosser, USA

  • 05 min

    Live Q&A with Chris Blosser, USA

  • 25 min

    Presentation: New onset diabetes after transplantation: epidemiology and management, Wai Lim, Australia

  • 05 min

    Live Q&A with Wai Lim, Australia

  • 20 min

    Interactive panel discussion with audience participation led by the Chairs

  • 05 min

    Masterclass closing remarks

Join Our Mailing List


Invalid Input
Invalid Input
Invalid email address

Please select at least one of the newsletters

Ask a Question


Invalid Input
Invalid Input
Invalid email address
Please type in your question

Masterclass Prospectus Request


Submit the following information to receive the downloadable prospectus instantaneously.

Invalid Input
Invalid Input
Invalid email address
Invalid Input
Invalid Input